January 22, 2018
Novartis buys French radiopharmaceutical company AAA for $3.9 billion
Novartis Group France has completed a tender to buy Advanced Accelerator Applications S.A. for $3,9 billion, or $41.00 per ordinary…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
January 22, 2018
Silence Therapeutics nets important patent in Europe
Silence Therapeutics strengthen the protection for its innovative chemical modification technology in Europe, as the European Patent Office granted it…
January 22, 2018
Celgene Corporation to acquire Juno Therapeutics, building global leadership in cellular immunotherapy
Celgene Corporation will acquire Juno Therapeutics, it has been announced as the two companies have signed a merger agreement.
January 22, 2018
European Commission OK’s BMS’s Yervoy for children with unresectable or metastatic melanoma
In addition to today’s news about Yervoy in combination with Opdivo , Bristol-Myers Squibb said today that the European Commission (EC) has…
January 22, 2018
BMS says Opdivo and Yervoy benefitial for patients with certain metastatic colorectal cancer
Bristol-Myers Squibb Company today said that new data from a cohort of the phase 2 CheckMate -142 test of the…
January 22, 2018
Sanofi goes shopping, buys Bioverativ, for $11.6 billion, adds hemophilia and other rare blood disorders specialist to the basket
Sanofi will buy Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, for $11,6…
January 19, 2018
Bavarian Nordic kicks-off cancer candidate trial
Bavarian Nordic said Friday that it has kicked off a clinical trial of BN-Brachyury, a novel cancer immunotherapy candidate designed…
January 19, 2018
AstraZeneca does business in Japan, another approval today, for Fasenra
AstraZeneca and its global biologics research and development arm, MedImmune, said on Friday that the Japanese Ministry of Health, Labour…
January 19, 2018
AZ’s Lynparza approved in Japan for the treatment of advanced ovarian cancer
AstraZeneca and Merck have announced that the Japanese Ministry of Health, Labour and Welfare has approved Lynparza (olaparib) tablets (300mg…
January 19, 2018
Sandoz announces exclusive global collaboration with Biocon on next-generation biosimilars
Sandoz, a Novartis division and the global leader in biosimilars, today announced a global partnership with Asia’s premier biopharmaceuticals company,…